News Article

Statement on Medicaid and ACA Cuts in Newly Passed Legislation

Eduardo Conrado
Eduardo Conrado
President and Chief Executive Officer, Ascension

“We are deeply disappointed with the cuts to Medicaid and the Affordable Care Act in legislation known as the One Big Beautiful Bill Act that passed Congress today. This bill falls short of supporting individuals and families who are poor, vulnerable, or too often left out of important decisions in Washington, causing nearly 12 million to lose their health coverage. While we do not expect immediate operational changes, these cuts risk destabilizing the health care system, especially in rural and underserved areas. As a Catholic health ministry dedicated to serving all, we remain committed to advocating for those who may not have a voice in policy conversations. Our Mission has not changed. We will continue to provide compassionate, high-quality care to everyone we serve, with special attention to those most in need, regardless of their health coverage status.” - Eduardo Conrado, President of Ascension

Recent National News
How Ascension is investing in imaging to expand access, strengthen clinical capabilities, and support faster diagnoses
News Articles

How Ascension is investing in imaging to expand access, strengthen clinical capabilities, and support faster diagnoses

Ascension’s imaging strategy builds on a broad foundation of scale, clinical excellence, and community reach.
Expanding access to specialty care through digital innovation
News Articles

Expanding access to specialty care through digital innovation

As demand for specialty care continues to grow, Ascension is transforming how neurological and behavioral health care is delivered through a connected virtual care infrastructure.
Ascension Chief Pharmacy Officer Mike Wascovich Named to Becker's Hospital Review's
News Articles

Ascension Chief Pharmacy Officer Mike Wascovich Named to Becker's Hospital Review's "Chief Pharmacy Officers to Know" List

The annual list recognizes pharmacy leaders who are advancing medication safety, improving access to care, driving innovation, and helping health systems navigate an increasingly complex pharmaceutical landscape.